These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 26873446)
1. New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions. Makarava N; Savtchenko R; Alexeeva I; Rohwer RG; Baskakov IV Am J Pathol; 2016 Apr; 186(4):1006-14. PubMed ID: 26873446 [TBL] [Abstract][Full Text] [Related]
2. Two alternative pathways for generating transmissible prion disease de novo. Makarava N; Savtchenko R; Baskakov IV Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038 [TBL] [Abstract][Full Text] [Related]
3. A new mechanism for transmissible prion diseases. Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680 [TBL] [Abstract][Full Text] [Related]
4. Generation of genuine prion infectivity by serial PMCA. Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773 [TBL] [Abstract][Full Text] [Related]
5. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901 [TBL] [Abstract][Full Text] [Related]
6. Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles. Kovacs GG; Makarava N; Savtchenko R; Baskakov IV Am J Pathol; 2013 Nov; 183(5):1539-1547. PubMed ID: 24012784 [TBL] [Abstract][Full Text] [Related]
7. Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification. Makarava N; Savtchenko R; Baskakov IV J Biol Chem; 2013 Jan; 288(1):33-41. PubMed ID: 23168413 [TBL] [Abstract][Full Text] [Related]
8. Autocatalytic self-propagation of misfolded prion protein. Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610 [TBL] [Abstract][Full Text] [Related]
9. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice. Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027 [TBL] [Abstract][Full Text] [Related]
10. Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions. Gao C; Han J; Zhang J; Wei J; Zhang BY; Tian C; Zhang J; Shi Q; Dong XP Mol Neurobiol; 2017 Jul; 54(5):3771-3782. PubMed ID: 27259989 [TBL] [Abstract][Full Text] [Related]
11. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein. Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R Prion; 2014; 8(4):314-8. PubMed ID: 25482603 [TBL] [Abstract][Full Text] [Related]
12. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein. Piening N; Weber P; Giese A; Kretzschmar H Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583 [TBL] [Abstract][Full Text] [Related]
13. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate. Faburay B; Tark D; Kanthasamy AG; Richt JA Prion; 2014; 8(6):393-403. PubMed ID: 25495764 [TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives. Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein. Kim DH; Lee HM; Ryou C J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058 [TBL] [Abstract][Full Text] [Related]
18. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933 [TBL] [Abstract][Full Text] [Related]
19. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194 [TBL] [Abstract][Full Text] [Related]
20. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras. Kupfer L; Eiden M; Buschmann A; Groschup MH Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]